feed,title,long_url,short_url
Benzinga,"Johnson & Johnson's Clock 12% Q4 Revenue Growth, Cancer and Crohn's Disease Drugs Account as Largest Sellers",https://benzinga.com/general/biotech/24/01/36738885/johnson-johnsons-clock-12-q4-revenue-growth-cancer-and-crohns-disease-drugs-account-as-largest-se,https://da.gd/7nnqky
